Announcement on the Definition of the Properties of the Fourth Batch of Drug Combination Products
Pharmaceutical Network January 3 hearing in order to guide the applicant to declare a reasonable, now the fourth batch of combination of drug product portfolio properties to be announced results.
Special announcement.
Annex: the fourth batch of combination of drug product portfolio definition results summary
Serial number
Application to define the time
Application unit
product name
Define the conclusion
1
July 3, 2017
Wuhan Wisconsin Medical Technology Co., Ltd.
Functional collagen sponge
Drug products do not belong to the portfolio should be declared by the drug
2
August 24, 2017
Katherine Pharmaceutical (Hefei) Co., Ltd.
Prefilled ropivacaine hydrochloride injection continuous administration system
Drug-based combination of drug products
3
September 7, 2017
Shanghai Mei Bao Life Technology Co., Ltd.
Medical functional wound dressing
Drug-based combination of drug products
4
September 18, 2017
Beijing Novartis Pharmaceutical Co., Ltd.
Secukinumab injection
Drug products do not belong to the portfolio should be declared by the drug
